The metabolic syndrome adds incremental value to the Framingham risk score in identifying asymptomatic individuals with higher degrees of inflammation.

Journal of the cardiometabolic syndrome

Volumn 3, Issue 1, 2008, Pages 7-11

  Campbell, Catherine Y ^a   Nasir, Khurram ^a   Carvalho, Jose A M ^a   Blumenthal, Roger S ^a   Santos, Raul D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; BRAZIL; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; HUMAN; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NONPARAMETRIC TEST; PREDICTION AND FORECASTING; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

BIOLOGICAL MARKERS; BRAZIL; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 45149107840     PISSN: 15594564     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1559-4572.2008.06670.x     Document Type: Article

References (0)